Welcome to our dedicated page for Varex Imaging news (Ticker: VREX), a resource for investors and traders seeking the latest updates and insights on Varex Imaging stock.
Varex Imaging Corporation reports developments tied to its X-ray imaging component business, including X-ray tubes, digital detectors, connecting devices, imaging software and industrial X-ray systems. Company news commonly covers results from its Medical and Industrial segments, demand trends in CT products, cargo security systems and photon counting detectors, and updates for products used by global OEM manufacturers in medical, industrial and security imaging applications.
Recurring announcements also include earnings releases and conference calls, investor conference participation, and capital-structure actions such as the refinancing of secured debt and redemption of senior secured notes.
Varex Imaging (Nasdaq: VREX) will report unaudited results for Q1 fiscal 2026 after market close on Tuesday, February 10, 2026. A conference call will follow at 3:00 pm Mountain Time the same day and will be webcast live at the company’s investor site.
Investors can join by phone at 877-524-8416 (U.S.) or 412-902-1028 (non-U.S.). A replay will be available from February 10–24, 2026 with access code 13758188. Varex is headquartered in Salt Lake City and employs ~2,400 people worldwide; it designs and manufactures X-ray imaging components and systems for medical, industrial and security uses.
Varex (Nasdaq: VREX) said company management will present at the CJS Securities 26th Annual New Ideas for the New Year Virtual Conference on Wednesday, January 14, 2026 at 3:50pm ET. The presentation will be available via webcast and can be accessed on Varex’s investor website at www.vareximaging.com/news.
Varex (Nasdaq: VREX) reported Q4 FY2025 and full-year results on November 18, 2025. Q4 revenue was $229M (+11% YoY); Medical $152M (+5% YoY) and Industrial $77M (+25% YoY). Q4 non-GAAP gross margin was 34% and non-GAAP EPS was $0.37 (vs $0.19 a year ago). FY2025 revenue was $845M (+4% YoY); non-GAAP EBITDA rose 37% to $122M and non-GAAP EPS was $0.90 (+73%). Cash and equivalents were $155M at year-end after paying principal on convertible notes on June 2, 2025. Q1 FY2026 guidance: revenue $200–$215M, non-GAAP EPS $0.05–$0.25. Conference call held Nov 18, 2025.
Varex Imaging (Nasdaq: VREX) will report unaudited financial results for the fourth quarter and fiscal year 2025 after market close on Tuesday, November 18, 2025. A conference call and live webcast will follow at 3:00 PM Mountain Time that day.
Investors can join the live webcast at www.vareximaging.com/investor-relations/ or by phone at 877-524-8416 (U.S.) and 412-902-1028 (non-U.S.). The call webcast will be archived and a replay will be available from November 18 through December 2, 2025 at 877-660-6853 (U.S.) or 201-612-7415 (non-U.S.) using access code 13756256.
Varex designs and manufactures X-ray imaging components and systems and is headquartered in Salt Lake City, employing about 2,300 people globally.
Varex Imaging Corporation (Nasdaq: VREX) announced its upcoming participation in the Sidoti Small Cap Virtual Conference. The company's management team will deliver a presentation on Wednesday, September 17, 2025 at 3:15 PM ET. Investors can access the webcast through the provided link or via Varex's corporate website at vareximaging.com/news.
Varex Imaging (NASDAQ: VREX) reported Q3 FY2025 financial results with revenues of $203 million, exceeding guidance but down 3% year-over-year. The company's Medical segment revenue decreased 4% to $142 million, while the Industrial segment revenue grew 1% to $61 million.
Non-GAAP gross margin improved to 34% from 32% in Q3 FY2024, with non-GAAP EPS increasing to $0.18 from $0.14. Operating cash flow was $8 million, with cash and equivalents at $153 million after paying down Convertible Notes. For Q4 FY2025, Varex expects revenues between $210-230 million and non-GAAP EPS of $0.10-0.30.
Varex Imaging Corporation (Nasdaq: VREX), a leading manufacturer of X-ray imaging components, has scheduled its third quarter fiscal year 2025 earnings release and conference call. The company will announce its unaudited financial results on Thursday, August 7, 2025, after market close, followed by a conference call at 3:00 PM Mountain Time.
Investors can access the conference call via U.S. toll-free number (877-524-8416) or international number (412-902-1028). The webcast will be available on the company's investor relations website, with a replay accessible through August 21st using access code 13754994.
Varex Imaging (Nasdaq: VREX) has secured new orders worth $17 million for its high-energy non-intrusive cargo and vehicle inspection systems from international customers. The systems will be deployed at strategic sea and land ports for security purposes.
CEO Sunny Sanyal highlighted that the company's Cargo Systems business has received orders totaling over $55 million year-to-date, demonstrating Varex's strong position in high-energy Linear Accelerator based imaging technology and its integration capabilities.
Varex Imaging Corporation (VREX) has announced its participation in the upcoming Jefferies Global Healthcare Conference in New York. The company's management team is scheduled to deliver a presentation on Wednesday, June 4, 2025, at 8:10 AM ET. Interested parties can access the webcast through a provided link or via Varex's official website at www.vareximaging.com/news.